3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Breast Neoplasms
677
Neoplasms
593
Colorectal Neoplasms
292
Carcinoma, Non-Small-Cell Lung
292
Prostatic Neoplasms
281
Lung Neoplasms
223
Melanoma
161
Multiple Myeloma
150
Neoplasm Metastasis
146
Head and Neck Neoplasms
143
Pancreatic Neoplasms
141
Ovarian Neoplasms
133
Carcinoma, Hepatocellular
126
Leukemia, Myeloid, Acute
123
Colonic Neoplasms
112
Brain Neoplasms
112
Squamous Cell Carcinoma of Head and Neck
111
Uterine Cervical Neoplasms
108
Stomach Neoplasms
105
Recurrence
101
Lymphoma
101
Glioblastoma
94
Precursor Cell Lymphoblastic Leukemia-Lymphoma
82
Lymphoma, Non-Hodgkin
82
Hematologic Neoplasms
80
Urinary Bladder Neoplasms
78
Lymphoma, Follicular
78
Glioma
75
Parkinson Disease 4, Autosomal Dominant Lewy Body
74
Leukemia, Lymphocytic, Chronic, B-Cell
72
Interventions
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Aspergillosis
×
1 year
×
Clear all
NCT02955966
2025-11-20
OPTIFIL
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
51 enrolled
NCT03349931
2025-11-20
MYCOGENIE
Assistance Publique - Hôpitaux de Paris
Completed
350 enrolled